Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 104 for:    colon cancer | ( Map: Nebraska, United States )

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03365882
Recruitment Status : Active, not recruiting
First Posted : December 7, 2017
Last Update Posted : June 26, 2019
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 1, 2021
Estimated Study Completion Date : June 15, 2023